Who invested in Electra Therapeutics

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$183Mraised across 1 round since 2025, from 1 source

Latest round: Series C, $183MOct 2025
Investors: 5

See who backed them

The rounds

Oct 2025
Series C$183M
Source recordedSEC filing: $134M sold, first sale Oct 2025

Founders and team

From Electra Therapeutics's own website: 6 on the team.

Gary S. Koe PhDChief Technical Officer
Graham Parry PhDChief Scientific Officer
Adam Rosenthal PhDDirector
Beth SeidenbergDirector
Nancy Stagliano PhDExecutive Chair
Thomas GeninattiDirector

Everyone who backed them

RA Capital ManagementPrivate equity1round

Cormorant Asset ManagementPrivate equity1round

SanofiInvestment firm1round

MubadalaPrivate equity1round

Blue OwlAsset manager1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Electra Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.